| Dr Robert Ray Blocker, MD | |
|
4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 | |
| (801) 387-2800 | |
| Not Available |
| Full Name | Dr Robert Ray Blocker |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 4401 Harrison Boulevard, Ogden, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740401645 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 5763801-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Layton Hospital | Layton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain West Anesthesia Llc | 9032018502 | 248 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences, Inc. under which Mylan has licensed the non-exclusive rights to manufacture and distribute Tenofovir Alafenamide (TAF) as both a single agent product and in combination with other drugs.
"A campaign to introduce new childhood vaccines to Haiti will save tens of thousands of lives over the next decade, CDC Director Dr. Thomas Frieden told NPR's health blog 'Shots' at the end of a two-day tour of the beleaguered country," the blog reports.
Americans have had little understanding of the Affordable Care Act since it became law in 2010. With major provisions taking effect in January, half the country still does not know what the law does or what it means for them. While some of the confusion is no doubt due to the law's complexity and the highly charged political environment, a largely ignored but central factor is that people know little about the deeply flawed health insurance system that got us to this place (John Seffrin and Jim Guest, 9/17).
A recent study published on the preprint server bioRxiv* seeks to establish the pattern of antibody reactivity in COVID-19 convalescent plasma (CCP), which is widely being used as a therapy for seriously ill COVID-19 patients.
Despite receiving blood thinners and other clot prevention treatment, some patients still develop potentially lethal blood clots in the first month after their operations anyway, especially if they developed a surgical-site infection while in the hospital, according to results of a study at Johns Hopkins.
› Verified 3 days ago
| Entity Name | Mountain West Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558391763 PECOS PAC ID: 9032018502 Enrollment ID: O20040103000057 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences, Inc. under which Mylan has licensed the non-exclusive rights to manufacture and distribute Tenofovir Alafenamide (TAF) as both a single agent product and in combination with other drugs.
"A campaign to introduce new childhood vaccines to Haiti will save tens of thousands of lives over the next decade, CDC Director Dr. Thomas Frieden told NPR's health blog 'Shots' at the end of a two-day tour of the beleaguered country," the blog reports.
Americans have had little understanding of the Affordable Care Act since it became law in 2010. With major provisions taking effect in January, half the country still does not know what the law does or what it means for them. While some of the confusion is no doubt due to the law's complexity and the highly charged political environment, a largely ignored but central factor is that people know little about the deeply flawed health insurance system that got us to this place (John Seffrin and Jim Guest, 9/17).
A recent study published on the preprint server bioRxiv* seeks to establish the pattern of antibody reactivity in COVID-19 convalescent plasma (CCP), which is widely being used as a therapy for seriously ill COVID-19 patients.
Despite receiving blood thinners and other clot prevention treatment, some patients still develop potentially lethal blood clots in the first month after their operations anyway, especially if they developed a surgical-site infection while in the hospital, according to results of a study at Johns Hopkins.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Ray Blocker, MD 3340 North Center St, #800, Lehi, UT 84043-7406 Ph: (801) 990-1911 | Dr Robert Ray Blocker, MD 4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 Ph: (801) 387-2800 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences, Inc. under which Mylan has licensed the non-exclusive rights to manufacture and distribute Tenofovir Alafenamide (TAF) as both a single agent product and in combination with other drugs.
"A campaign to introduce new childhood vaccines to Haiti will save tens of thousands of lives over the next decade, CDC Director Dr. Thomas Frieden told NPR's health blog 'Shots' at the end of a two-day tour of the beleaguered country," the blog reports.
Americans have had little understanding of the Affordable Care Act since it became law in 2010. With major provisions taking effect in January, half the country still does not know what the law does or what it means for them. While some of the confusion is no doubt due to the law's complexity and the highly charged political environment, a largely ignored but central factor is that people know little about the deeply flawed health insurance system that got us to this place (John Seffrin and Jim Guest, 9/17).
A recent study published on the preprint server bioRxiv* seeks to establish the pattern of antibody reactivity in COVID-19 convalescent plasma (CCP), which is widely being used as a therapy for seriously ill COVID-19 patients.
Despite receiving blood thinners and other clot prevention treatment, some patients still develop potentially lethal blood clots in the first month after their operations anyway, especially if they developed a surgical-site infection while in the hospital, according to results of a study at Johns Hopkins.
› Verified 3 days ago
Mark S Naisbitt, M.D., PC Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 Phone: 801-507-5248 Fax: 801-733-5618 | |
Dr. John L Haws, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 Phone: 801-507-5248 | |
Bryce Larre Egbert, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-2800 Fax: 770-701-6675 | |
Dr. Andrew W. Allen, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-727-2056 Fax: 770-701-6675 | |
Michael Laurence Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 Phone: 801-507-5248 | |
Mr. Spencer B Hyde, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-2800 Fax: 770-701-6675 | |
Brian K Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 Phone: 801-507-5248 Fax: 801-733-5618 |